Xing-Guang Liang1, Chao Tan2, Cheng-Kun Wang2, Rong-Rong Tao2, Yu-Jie Huang1, Kui-Fen Ma1, Kohji Fukunaga3, Ming-Zhu Huang1, Feng Han2. 1. Central Laboratory, School of Medicine, First Affiliated Hospital, Zhejiang University, Hangzhou, China. 2. Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China. 3. Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
Abstract
OBJECTIVE: The cholinergic deficit is thought to underlie progressed cognitive decline in Alzheimer Disease. The lineage reprogramming of somatic cells into cholinergic neurons may provide strategies toward cell-based therapy of neurodegenerative diseases. METHODS AND RESULTS: Here, we found that a combination of neuronal transcription factors, including Ascl1, Myt1l, Brn2, Tlx3, and miR124 (5Fs) were capable of directly converting human brain vascular pericytes (HBVPs) into cholinergic neuronal cells. Intriguingly, the inducible effect screening of reprogramming factors showed that a single reprogramming factor, Myt1l, induced cells to exhibit similarly positive staining for Tuj1, MAP2, ChAT, and VAChT upon lentivirus infection with the 5Fs after 30 days. HBVP-converted neurons were rarely labeled even after long-term incubation with BrdU staining, suggesting that induced neurons were directly converted from HBVPs rather than passing through a proliferative state. In addition, the overexpression of Myt1l induced the elevation of Ascl1, Brn2, and Ngn2 levels that contributed to reprogramming. CONCLUSIONS: Our findings provided proof of the principle that cholinergic neurons could be produced from HBVPs by reprogramming factor-mediated fate instruction. Myt1l was a critical mediator of induced neuron cell reprogramming. HBVPs represent another excellent alternative cell resource for cell-based therapy to treat neurodegenerative disease.
OBJECTIVE: The cholinergic deficit is thought to underlie progressed cognitive decline in Alzheimer Disease. The lineage reprogramming of somatic cells into cholinergic neurons may provide strategies toward cell-based therapy of neurodegenerative diseases. METHODS AND RESULTS: Here, we found that a combination of neuronal transcription factors, including Ascl1, Myt1l, Brn2, Tlx3, and miR124 (5Fs) were capable of directly converting human brain vascular pericytes (HBVPs) into cholinergic neuronal cells. Intriguingly, the inducible effect screening of reprogramming factors showed that a single reprogramming factor, Myt1l, induced cells to exhibit similarly positive staining for Tuj1, MAP2, ChAT, and VAChT upon lentivirus infection with the 5Fs after 30 days. HBVP-converted neurons were rarely labeled even after long-term incubation with BrdU staining, suggesting that induced neurons were directly converted from HBVPs rather than passing through a proliferative state. In addition, the overexpression of Myt1l induced the elevation of Ascl1, Brn2, and Ngn2 levels that contributed to reprogramming. CONCLUSIONS: Our findings provided proof of the principle that cholinergic neurons could be produced from HBVPs by reprogramming factor-mediated fate instruction. Myt1l was a critical mediator of induced neuron cell reprogramming. HBVPs represent another excellent alternative cell resource for cell-based therapy to treat neurodegenerative disease.
Authors: Moritz Mall; Michael S Kareta; Soham Chanda; Henrik Ahlenius; Nicholas Perotti; Bo Zhou; Sarah D Grieder; Xuecai Ge; Sienna Drake; Cheen Euong Ang; Brandon M Walker; Thomas Vierbuchen; Daniel R Fuentes; Philip Brennecke; Kazuhiro R Nitta; Arttu Jolma; Lars M Steinmetz; Jussi Taipale; Thomas C Südhof; Marius Wernig Journal: Nature Date: 2017-04-05 Impact factor: 49.962
Authors: Zhiping P Pang; Nan Yang; Thomas Vierbuchen; Austin Ostermeier; Daniel R Fuentes; Troy Q Yang; Ami Citri; Vittorio Sebastiano; Samuele Marro; Thomas C Südhof; Marius Wernig Journal: Nature Date: 2011-05-26 Impact factor: 49.962
Authors: Soham Chanda; Cheen Euong Ang; Jonathan Davila; ChangHui Pak; Moritz Mall; Qian Yi Lee; Henrik Ahlenius; Seung Woo Jung; Thomas C Südhof; Marius Wernig Journal: Stem Cell Reports Date: 2014-07-04 Impact factor: 7.765
Authors: Thomas Vierbuchen; Austin Ostermeier; Zhiping P Pang; Yuko Kokubu; Thomas C Südhof; Marius Wernig Journal: Nature Date: 2010-01-27 Impact factor: 49.962
Authors: Roxanne Hsiang-Chi Liou; Thomas L Edwards; Keith R Martin; Raymond Ching-Bong Wong Journal: Int J Mol Sci Date: 2020-06-16 Impact factor: 5.923